Bayer reorganizes its businesses; NantKwest fills out exec ranks;

@FierceBiotech: Why would Martin Shkreli hike an old drug price by 5000%? Only a 'moron' would ask. More | Follow @FierceBiotech

@JohnCFierce: The British papers seem particularly outraged by Shkreli. Feeling a bit sorry/outraged for the Yanks? Understandable. | Follow @JohnCFierce

@DamianFierce: "Industry analysts often cite the day Taiwanese animators got involved as the peak of the biotech bubble." Watch | Follow @DamianFierce

> Starting next year, Bayer will divide its business between pharmaceuticals, consumer health and crop science, a move the company said will better integrate its global divisions. News

> Patrick Soon-Shiong's NantKwest ($NK) is filling out its upper ranks after a record-setting IPO, recruiting a new executive medical director, senior vice president of medical affairs and senior vice president mergers and acquisitions. More

> Ampio Pharmaceuticals ($AMPE) is moving forward with a second Phase III trial on its treatment for osteoarthritis pain after the FDA signed off on a special protocol assessment. Item

Medical Device News

@FierceMedDev: Sequenom appoints new CEO amid diversification. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: CMS proposal to restrict coverage of artificial limbs facing pushback from amputees. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Clorox reveals smartphone-powered UV cleaning device for drug-resistant bacteria. Article | Follow @EmilyWFierce

> Biogen VP Karaboutis rallies company for med tech R&D push. More

> NIH gives med tech company $1.9M to improve deep brain stimulation for Parkinson's. Story

Pharma News

@FiercePharma: China's WuXi NextCODE builds on Fudan University partnership with Children's Hospital pact. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Novo to build a $78M insulin pen plant in Iran. FiercePharmaManufacturing news | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: New ulcerative colitis data could help Pfizer's Xeljanz pick up the pace. Article | Follow @CarlyHFierce

> Valeant's latest tax-cutting tactic, courtesy of Luxembourg. Report

> J&J faces Tylenol lobbying allegations in first case to go to trial over med. Story

> Rough waters for pharma's U.S. pricing power, yes. Sea change? Nope. Article

Drug Delivery News

> Drug-carrying nanoparticles disguised as platelets could help heal blood vessels. Report

> BDSI touts fed's plan to remove barriers on medication-assisted treatment of drug addiction. More

> West Pharma adds medication adherence tracking capability to its drug delivery system. Item

> Silicone vaginal ring could deliver HIV, herpes drugs at low cost. Story

> Impel NeuroPharma bags $4M to develop its device to deliver drugs across blood-brain barrier. Article

Pharma Manufacturing News

> Huge Russian plasma products plant moving forward. Article

> Novo to build $78M plant in Iran. News

> China's ShangPharma to build biologics plant in Qidong. Story

> GSK sets up network to help its suppliers cut emissions. Item

> McKesson nails down another international supply chain deal. Report

Pharma Asia News

> Serum Institute pushes for dengue cure fast track, Times of India says. Article

> WuXi NextCODE bolsters Fudan University alliance with Children's Hospital pact. News

> Novartis CEO says company to make heart failure drug Entresto at Singapore plant. Item

> Shanghai-based ZAI Lab in-licenses autoimmune candidate from UCB. Story

> China's BGI and Huawei partner on Big Data genomic system storage. More

Suggested Articles

The financing sets AM-Pharma up to advance in sepsis-associated acute kidney injury independently now Pfizer has turned down its option to buy.

The FDA sent Eton's partner, Bausch Health, a complete response letter that raised “no concerns” about the clinical data in the drug’s application.

A new partnership will test drug cocktails containing Karyopharm's new product Xpovio in cell samples from glioblastoma patients.